These companies are all long-time reliable dividend payers, with two of them just one year away from attaining dividend king status, as their dividend streaks now stand at 49 years. The third’s back-to-back 10%-plus annual dividend increases show that the company expects earnings per share to grow meaningfully. Investors looking for quality blue-chip healthcare stocks should start with these three: Abbott Laboratories (NYSE:ABT), Becton, Dickinson & Co. (NYSE:BDX) and Merck & Company (NYSE:MRK).
Source: InvestorPlace
Related Articles:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.